Ring systems in mutagenicity databases

Journal of Medicinal Chemistry

Volumn 48, Issue 21, 2005, Pages 6671-6678

  Kho, Richard ^a   Hodges, Jason A ^a   Hansen, Mark R ^a   Villar, Hugo O ^a  

^a Altoris Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AJMALINE; ATROPINE; COCAINE; DOLASETRON MESILATE; ESTRAZINOL; IMIDAZOLE DERIVATIVE; LOFENTANIL; LORCAINIDE; MUTAGENIC AGENT; NAPHTHALENE DERIVATIVE; NEW DRUG; PANCOPRIDE; PIPERAZINE DERIVATIVE; PYRIDINE DERIVATIVE; PYRROLINE DERIVATIVE; QUINIDINE; RODOCAINE; SCOPOLAMINE; THENALIDINE; UNCLASSIFIED DRUG;

ALGORITHM; AMES TEST; ARTICLE; CALCULATION; CHEMICAL STRUCTURE; DATA BASE; DRUG DESIGN; MUTAGENICITY; PREDICTION; STATISTICAL ANALYSIS;

CONFIDENCE INTERVALS; DATABASES, FACTUAL; DRUG DESIGN; HETEROCYCLIC COMPOUNDS; HYDROCARBONS, CYCLIC; MOLECULAR STRUCTURE; MUTAGENS; PHARMACEUTICAL PREPARATIONS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 27144514431     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm050564j     Document Type: Article

References (25)

1. Luch, A. Nature and nurture. Lessons from chemical carcinogenesis. Nat. Rev. Cancer 2005, 5, 113-125.
2. MacGregor, J. T.; Casciano, D.; Muller, L. Strategies and testing methods for identifying mutagenic risks. Mutat. Res. 2000, 455, 3-20.
3. Josephy, P. D.; Cruz, P.; Nohmi, T. Recent advances in the construction of bacterial genotoxicity assays. Mutat. Res. 1997, 386, 1-23.
4. Maron, D. M.; Ames, B. N. Revised methods for the Salmonella mutagenicity test. Mutat. Res. 1983, 113, 173-215.
5. McCann, J.; Ames, B. N. Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals: discussion. Proc. Natl. Acad. Sci. U.S.A. 1976, 73, 950-954.
6. Mortelmans, K.; Zeiger, E. The Ames Salmonella/microsome mutagenicity assay. Mutat. Res. 2000, 455, 29-60.
7. Fenech, M. The in vitro micronucleus technique. Mutat. Res. 2000, 455, 81-95.
8. Marzin, D. New approaches to estimating the mutagenic potential of chemicals. Cell Biol. Toxicol. 1999, 15, 359-365.
9. Atterwill, C. K.; Wing, M. G. In vitro preclinical lead optimisation technologies (PLOTs) in pharmaceutical development. Toxicol. Lett. 2002, 127, 143-151.
10. Kirkland, D. J., Gatehouse, D. G., Scott, D., Cole, J., Richold, M., Eds.; Basic Mutagenicity Tests: UKEMS Recommended Procedures; Cambridge University Press: Cambridge, U.K., 1990.
11. Gatehouse, D.; Haworth, S.; Cebula, T.; Gocke, E.; Kier, L.; Matsushima, T.; Melcion, C.; Nohmi, T.; Ohta, T.; Venitt, S.; Zieger, E. Recommendations for the performance of bacterial mutation assays. Mutat. Res. 1994, 312, 217-233.
12. Dearden, J. C. In silico prediction of drug toxicity. J. Comput. Aided. Mol. Des. 2003, 17, 119-127.
13. Kazius, J.; McGuire, R.; Bursi, R. Derivation and validation of toxicophores for mutagenicity prediction. J. Med. Chem. 2005, 48, 312-320.
14. Patlewicz, G.; Rodford, R.; Walker, J. D. Quantitative structure-activity relationships for predicting mutagenicity and carcinogenicity. Environ. Toxicol. Chem. 2003, 22, 1885-1893.
15. Klopman, G.; Zhu, H.; Fuller, M. A.; Saiakhov, R. D. Searching for an enhanced predictive tool for mutagenicity. SAK QSAR Environ. Res. 2004, 15, 251-263.
16. Cariello, N. F.; Wilson, J. D.; Britt, B. H.; Wedd, D. J.; Burlinson, B.; Gombar, V. Comparison of the computer programs DEREK and TOPKAT to predict bacterial mutagenicity. Deductive estimate of risk from existing knowledge. Toxicity prediction by komputer assisted technology. Mutagenesis 2002, 17, 321-329.
17. Snyder, R. D.; Pearl, G. S.; Mandakas, G.; Choy, W. N.; Goodsaid, F.; Rosenblum, I. Y. Assessment of the sensitivity of the computational programs DEREK, TOPKAT, and MCASE in the prediction of the genotoxicity of pharmaceutical molecules. Environ. Mol. Mutagen. 2004, 43, 143-158.
18. Rosenkranz, H. S.; Klopman, G. New structural concepts for predicting carcinogenicity in rodents: an artificial intelligence approach. Teratog., Carcinog., Mutagen. 1990, 10, 73-88.
19. Llorens, O.; Ferez, J. J.; Villar, H. O. Toward the design of chemical libraries for mass screening biased against mutagenic compounds. J. Med. Chem. 2001, 44, 2793-2804.
20. Llorens, O.; Ferez, J. J.; Villar, H. O. Investigation of structural and electronic biases in mutagenic compounds. Int. J. Quantum Chem. 2002, 88, 107-117.
21. See, for example, the following. Hegde, S.; Carter, J. To Market, To Market-2003. In Annual Reports in Medicinal Chemistry; Doherty, A. M., Ed.; Elsevier Acadmic Press: Amsterdam, 2004; Vol. 39, pp 337-368.
22. Bone, R. G. A.; Villar, H. O. Exhaustive enumeration of molecular substructures. J. Comput. Chem. 1997, 18, 86-107.
23. Wilkens, S. J.; Janes, J.; Su, A. I. HierS: Hierarchical scaffold clustering using topological chemical graphs. J. Med. Chem. 2005, 48, 3182-3193.
24. Foundations of Epidemiology, 3rd ed.; Lilienfeld, D. E., Stolley, P. D., Eds.; Oxford University Press: New York, 1994.
25. Wolter, K. M. Introduction to Variance Estimation; Springer-Verlag: New York, 1985.